MicroPort Scientific Corporation (MSK) - Total Assets
Based on the latest financial reports, MicroPort Scientific Corporation (MSK) holds total assets worth €3.77 Billion EUR (≈ $4.41 Billion USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See MicroPort Scientific Corporation (MSK) shareholders funds for net asset value and shareholders' equity analysis.
MicroPort Scientific Corporation - Total Assets Trend (2013–2024)
This chart illustrates how MicroPort Scientific Corporation's total assets have evolved over time, based on quarterly financial data.
MicroPort Scientific Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
MicroPort Scientific Corporation's total assets of €3.77 Billion consist of 47.8% current assets and 52.2% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 19.6% |
| Accounts Receivable | €265.64 Million | 7.3% |
| Inventory | €379.29 Million | 10.4% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €234.32 Million | 6.5% |
| Goodwill | €188.51 Million | 5.2% |
Asset Composition Trend (2013–2024)
This chart illustrates how MicroPort Scientific Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MicroPort Scientific Corporation market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MicroPort Scientific Corporation's current assets represent 47.8% of total assets in 2024, a decrease from 57.8% in 2013.
- Cash Position: Cash and equivalents constituted 19.6% of total assets in 2024, down from 30.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 5.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 10.4% of total assets.
MicroPort Scientific Corporation Competitors by Total Assets
Key competitors of MicroPort Scientific Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥1.34 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$127.41 Million |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.75 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Respiri Ltd
AU:RSH
|
Australia | AU$7.08 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Atomo Diagnostics Ltd
AU:AT1
|
Australia | AU$9.48 Million |
MicroPort Scientific Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.42 | 2.09 | 2.66 |
| Quick Ratio | 1.15 | 1.65 | 2.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €550.19 Million | €995.26 Million | €579.85 Million |
MicroPort Scientific Corporation - Advanced Valuation Insights
This section examines the relationship between MicroPort Scientific Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.19 |
| Latest Market Cap to Assets Ratio | 0.55 |
| Asset Growth Rate (YoY) | -7.6% |
| Total Assets | €3.63 Billion |
| Market Capitalization | $2.01 Billion USD |
Valuation Analysis
Below Book Valuation: The market values MicroPort Scientific Corporation's assets below their book value (0.55x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: MicroPort Scientific Corporation's assets decreased by 7.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MicroPort Scientific Corporation (2013–2024)
The table below shows the annual total assets of MicroPort Scientific Corporation from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €3.63 Billion ≈ $4.25 Billion |
-7.60% |
| 2023-12-31 | €3.93 Billion ≈ $4.60 Billion |
-1.54% |
| 2022-12-31 | €3.99 Billion ≈ $4.67 Billion |
-8.82% |
| 2021-12-31 | €4.38 Billion ≈ $5.12 Billion |
+77.41% |
| 2020-12-31 | €2.47 Billion ≈ $2.89 Billion |
+54.52% |
| 2019-12-31 | €1.60 Billion ≈ $1.87 Billion |
+25.38% |
| 2018-12-31 | €1.27 Billion ≈ $1.49 Billion |
+41.04% |
| 2017-12-31 | €903.62 Million ≈ $1.06 Billion |
+16.66% |
| 2016-12-31 | €774.55 Million ≈ $905.53 Million |
+5.58% |
| 2015-12-31 | €733.64 Million ≈ $857.71 Million |
-21.93% |
| 2014-12-31 | €939.73 Million ≈ $1.10 Billion |
+81.12% |
| 2013-12-31 | €518.85 Million ≈ $606.59 Million |
-- |
About MicroPort Scientific Corporation
MicroPort Scientific Corporation, together with its subsidiaries, engages in the innovating, manufacturing, and marketing medical devices globally in the People's Republic of China, Europe, Middle East and Africa, Japan, and internationally. The company's Cardiovascular Devices segment offers medical solutions for the treatment of coronary artery-related diseases; and coronary stents, related del… Read more